Co-Authors
This is a "connection" page, showing publications co-authored by Michael Kappelman and Ryan Ungaro.
Connection Strength
3.065
-
Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021 04; 70(4):725-732.
Score: 0.909
-
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry. Inflamm Bowel Dis. 2022 02 01; 28(2):314-317.
Score: 0.248
-
Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2021 Jun 28.
Score: 0.238
-
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States. Clin Gastroenterol Hepatol. 2021 10; 19(10):2210-2213.e3.
Score: 0.237
-
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry. Inflamm Bowel Dis. 2021 03 15; 27(4):585-589.
Score: 0.234
-
Reply. Gastroenterology. 2021 04; 160(5):1886-1887.
Score: 0.231
-
COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions. Gastroenterology. 2021 04; 160(5):1447-1451.
Score: 0.230
-
IBD in the COVID-19 era: the value of international collaboration. Lancet Gastroenterol Hepatol. 2020 10; 5(10):887-888.
Score: 0.226
-
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020 08; 159(2):481-491.e3.
Score: 0.221
-
The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry. J Crohns Colitis. 2021 Nov 08; 15(11):1877-1884.
Score: 0.061
-
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry. J Crohns Colitis. 2021 May 04; 15(5):860-863.
Score: 0.059
-
Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD Registry. Am J Gastroenterol. 2020 11; 115(11):1923-1924.
Score: 0.057
-
Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19. J Crohns Colitis. 2020 Oct 21; 14(14 Suppl 3):S769-S773.
Score: 0.057
-
Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases. Clin Gastroenterol Hepatol. 2021 02; 19(2):394-396.e5.
Score: 0.057